Inhibrx Biosciences director Jon Faiz Kayyem acquires $500,000 in common shares
INBX•Director reports indirect share purchase
- Inhibrx Biosciences director Jon Faiz Kayyem reported an indirect purchase of 5,000 common shares at USD 100 each.
- Family Trust holdings rose to 429,360 shares following the transaction.
